Cell-type-resolved mRNA 3′-end remodeling in Alzheimer’s disease

Inside every cell of the human brain, genetic instructions are stored in DNA, but these instructions are not read directly. Instead, the cell creates a working copy called messenger RNA, which carries the blueprint to the machinery that builds proteins. For decades, scientists believed that the most important part of this process was simply counting how many copies of a gene were made. If a gene was turned on, more copies were produced; if it was turned off, fewer copies appeared. This view treated the genetic message as a static volume knob, where the only thing that mattered was the loudness of the signal. However, a deeper layer of complexity exists. Before a messenger RNA molecule is finished, the cell must decide exactly where to cut it off. This decision, known as polyadenylation, determines the length of the tail at the end of the molecule. That tail acts like a set of instructions for how long the message should last, where it should travel within the cell, and how efficiently it should be translated into protein. Changing the length of this tail can alter the function of the protein or even change which protein is made entirely, without changing the number of copies of the gene itself.

A team of researchers at the Icahn School of Medicine at Mount Sinai has now mapped this hidden layer of genetic regulation across the human brain, revealing how it goes wrong in Alzheimer's disease. By examining the genetic material from over 1,400 human donors, they discovered that the brain uses a vast and previously uncharted variety of these cutting points. Their work shows that in Alzheimer's disease, the brain does not just lose genes or turn them down; it fundamentally rewrites the structure of its genetic messages. This rewriting happens in specific types of cells, such as the neurons that handle thought and memory, and it occurs even when the total amount of genetic material appears unchanged. The study suggests that the disease process involves a subtle but critical shift in how the brain edits its own instructions, a mechanism that standard genetic tests have largely missed.

To understand the scale of this discovery, the researchers had to build a new map from scratch. They analyzed data from 6.3 million individual brain nuclei, a massive collection that allowed them to see patterns that were invisible in smaller studies. They identified over 108,000 distinct cutting points where messenger RNA molecules end. Most of these points were not on any existing map of the human genome. In fact, only about one-quarter of the cutting points they found were listed in the standard reference guides used by scientists. The rest were new discoveries, many of which were located in unexpected places, such as deep inside the gene or far beyond the usual end of the instruction manual. This new catalog revealed that the brain is far more flexible in how it edits its messages than previously thought, with different cell types using different sets of cutting points to fine-tune their functions.

The researchers then looked at how this editing process changes as Alzheimer's disease progresses. They found a clear and consistent pattern in the cells that are most critical for brain function. In the excitatory neurons, which are the primary communication cells of the brain, and in the immune cells that patrol the brain, the disease causes a shift toward using cutting points that are further away from the start of the gene. This results in longer tails on the messenger RNA molecules. Conversely, the cells stop using cutting points that are located closer to the beginning, including those hidden inside the gene itself. This shift means that the brain is producing different versions of the same proteins, potentially altering their stability or where they go within the cell. The change is so widespread that it affects thousands of genes, particularly those involved in building and maintaining the connections between neurons, known as synapses.

What makes this finding particularly significant is that these changes happen independently of the total amount of genetic material. In many cases, the number of copies of a gene remained the same, yet the way the cell edited the message changed dramatically. This explains why previous studies that only counted gene copies failed to detect these critical alterations. The researchers confirmed that this pattern of longer tails and shifted cutting points was not a fluke of their specific data set. They found the same changes in independent groups of patients and even in purified immune cells from other studies. The consistency across different datasets suggests that this remodeling of the genetic message is a core feature of Alzheimer's disease, not just a side effect of aging or other factors.

The study also pointed toward the likely cause of this rewriting. The researchers examined the proteins responsible for making the cuts and found that one specific group of proteins, known as the cleavage factor Im complex, was behaving differently in the diseased brain. Specifically, a protein called NUDT21 was more active in the neurons of patients with Alzheimer's. This protein is known to influence where the cutting happens, and its increased activity aligns perfectly with the observed shift toward longer tails and the use of distant cutting points. While the researchers cannot yet say for certain that this protein is the sole driver of the disease, the evidence strongly suggests that a disruption in this editing machinery is a key part of what goes wrong in Alzheimer's.

These findings offer a new perspective on how Alzheimer's disease damages the brain. It is not merely a matter of losing genes or reducing their activity; it is a failure in the precise editing of the genetic instructions. The brain's ability to fine-tune its messages is compromised, leading to the production of proteins that may not function correctly or may not reach the right places. This layer of molecular pathology, hidden within the structure of the RNA itself, was invisible to conventional methods of analysis. By uncovering this mechanism, the researchers have provided a more complete picture of the disease, highlighting a new avenue for understanding how the brain fails and potentially opening doors for future investigations into how to restore the correct editing of genetic messages.